Sarbanes-Oxley Risk Assessment for Pharma/Bio/Life Science Industries

Instructor: Bob Benoit
Product ID: 700122
Training Level: Intermediate
  • Duration: 60 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

This SOX compliance training will provide a uniquely effective road map to documenting and assessing risks at Pharma/Bio/Life Science companies.

Sarbanes-Oxley Risk Assessment includes COSO, PCAOB Auditing Standard #2 and SEC/PCAOB Q&A’s. Recent PCAOB/SEC Internal Control Roundtables also reiterate the need for management and outside auditors to take a risk based, top down approach toward complying with SOX Section 404.

But what is there secret to effective and affordable compliance? The answer is ’working backwards’! Using database tools and web based technologies participants will learn from historical Section 404 results of peer company internal control and accounting deficiencies.

Areas Covered in the seminar:

  • What is the SOX regulatory environment over risk assessment?
  • What is the intent of risk assessment?
  • Focus on materiality
  • What advantage to MicroCap companies have?
  • What risks have companies in Pharma/Bio/Life Sciences peer groups experienced?
  • How do restatements affect risk?

Sarbanes-Oxley Article’s by Bob Benoit:

Who Will Benefit:

  • CFOs, Controllers, CIOs, CCOs
  • Management
  • Audit Committee members
  • Consultants
  • Software providers
  • Outside auditing firms
  • Legal professionals

Instructor Profile:

Bob Benoit is President and Director of SOX Research at Lord & Benoit, LLC, a national Sarbanes-Oxley Research and Compliance firm Bob has been teaching Compliance with Sarbanes-Oxley Section 404 throughout the U.S. through the State CPA Societies. He has been on Massachusetts AICPA Peer Review Acceptance Board for ten years. Bob’s research has been quoted by three of the Big 4 CPA firms, PCAOB, SEC, SEC Staff, SEC Advisory Committee and AICPA-CPCAF. His research has been featured in the Wall Street Journal, FEI,, and Sarbanes-Oxley Compliance Journal to name a few. Colleges, legal journals, CPA and other compliance firms have also referenced his work.

Follow us :
Latin America: Regulatory Compliance Requirements for Life Science Products
Upcoming In-person Seminars by EX-FDA OFFICIALS

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews Write review

Good benchmarking tool.
- Anonymous

Best Sellers
You Recently Viewed